Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CHECKPOINT INHIBITORS, . Treffer: 80

2025

Bräutigam, K; Skok, K; Szymonski, K; Rift, CV; Karamitopoulou, E Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - Exploring the "Space".
Cancer Lett. 2025; 622: 217699 Doi: 10.1016/j.canlet.2025.217699
Web of Science PubMed FullText FullText_MUG

 

Cerrato, G; Sauvat, A; Abdellatif, M; Kroemer, G Potent immune-dependent anticancer effects of the non-cardiotoxic anthracycline aclarubicin
ONCOIMMUNOLOGY. 2025; 14(1): 2515176 Doi: 10.1080/2162402X.2025.2515176 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Chen, YC; Dolladille, C; Rao, A; Palaskas, NL; Deswal, A; Lehmann, L; Cautela, J; Courand, PY; Hayek, S; Zhu, H; Cheng, RK; Alexandre, J; Baldassarre, LA; Roubille, F; Laufer-Perl, M; Asnani, A; Ederhy, S; Tamura, Y; Francis, S; Gaughan, EM; Johnson, DB; Flint, DL; Rainer, PP; Bailly, G; Ewer, SM; Aras, MA; Arangalage, D; Cariou, E; Florido, R; Peretto, G; Itzhaki, Ben, Zadok, O; Akhter, N; Narezkina, A; Levenson, JE; Liu, Y; Crusz, SM; Issa, N; Piriou, N; Leong, D; Sandhu, S; Turker, I; Moliner, P; Obeid, M; Heinzerling, L; Chang, WT; Stewart, A; Venkatesh, V; Du, Z; Yadavalli, A; Kim, D; Chandra, A; Zhang, KW; Power, JR; Moslehi, J; Salem, JE; Zaha, VG, , International, ICI, Myocarditis, Registry Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction.
JACC CardioOncol. 2025; 7(3):234-248 Doi: 10.1016/j.jaccao.2025.01.020 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Plass, M; Olteanu, GE; Dacic, S; Kern, I; Zacharias, M; Popper, H; Fukuoka, J; Ishijima, S; Kargl, M; Murauer, C; Kalson, L; Brcic, L Comparative performance of PD-L1 scoring by pathologists and AI algorithms.
Histopathology. 2025; Doi: 10.1111/his.15432 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Power, JR; Dolladille, C; Ozbay, B; Procureur, A; Ederhy, S; Palaskas, NL; Lehmann, LH; Cautela, J; Courand, PY; Hayek, SS; Zhu, H; Zaha, VG; Cheng, RK; Alexandre, J; Roubille, F; Baldassarre, LA; Chen, YC; Baik, AH; Laufer-Perl, M; Tamura, Y; Asnani, A; Francis, S; Gaughan, EM; Rainer, PP; Bailly, G; Flint, D; Arangalage, D; Cariou, E; Florido, R; Narezkina, A; Liu, Y; Sandhu, S; Leong, D; Issa, N; Piriou, N; Heinzerling, L; Peretto, G; Crusz, SM; Akhter, N; Levenson, JE; Turker, I; Eslami, A; Fenioux, C; Moliner, P; Obeid, M; Chan, WT; Ewer, SM; Kassaian, SE; Johnson, DB; Nohria, A; Ben, Zadok, OI; Moslehi, JJ; Salem, JE, , International, ICI-Myocarditis, Registry Immune checkpoint inhibitor-associated myocarditis: a novel risk score.
Eur Heart J. 2025; Doi: 10.1093/eurheartj/ehaf315
PubMed FullText FullText_MUG

 

Ristić, D; Bärnthaler, T; Gruden, E; Kienzl, M; Danner, L; Herceg, K; Sarsembayeva, A; Kargl, J; Schicho, R GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis.
Front Immunol. 2024; 15: 1513547 Doi: 10.3389/fimmu.2024.1513547 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sun, J; Huai, J; Zhang, W; Zhao, T; Shi, R; Wang, X; Li, M; Jiao, X; Zhou, X Therapeutic strategies for adrenocortical carcinoma: integrating genomic insights, molecular targeting, and immunotherapy.
Front Immunol. 2025; 16:1545012 Doi: 10.3389/fimmu.2025.1545012 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Theiler-Schwetz, V; Trummer, C; Schmitt, L; Terbuch, A; Obermayer-Pietsch, B; Richtig, E; Pilz, S High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial.
Ann Med. 2025; 57(1): 2453829 Doi: 10.1080/07853890.2025.2453829 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2024

Ascierto, PA; Casula, M; Bulgarelli, J; Pisano, M; Piccinini, C; Piccin, L; Cossu, A; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbe, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del Vecchio, M; Cao, MG; Minisini, AM; De Placido, S; Sanmamed, MF; Mallardo, D; Paone, M; Vitale, MG; Melero, I; Grimaldi, AM; Giannarelli, D; Dummer, R; Sileni, VC; Palmieri, G Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
NAT COMMUN. 2024; 15(1): 146 Doi: 10.1038/s41467-023-44475-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ascierto, PA; Mandalà, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, A; Guida, M; Maiello, E; Gogas, H; Richtig, E; Quaglino, P; Lebbé, C; Helgadottir, H; Queirolo, P; Spagnolo, F; Tucci, M; Del, Vecchio, M; Gonzalez-Cao, M; Minisini, AM; De, Placido, S; Sanmamed, MF; Casula, M; Bulgarelli, J; Pisano, M; Piccinini, C; Piccin, L; Cossu, A; Mallardo, D; Paone, M; Vitale, MG; Melero, I; Grimaldi, AM; Giannarelli, D; Palmieri, G; Dummer, R; Sileni, VC Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
NEJM Evid. 2024; 3(10): EVIDoa2400087 Doi: 10.1056/EVIDoa2400087
PubMed FullText FullText_MUG

 

Balcar, L; Scheiner, B; Fulgenzi, CAM; D'Alessio, A; Pomej, K; Roig, MB; Meyer, EL; Che, J; Nishida, N; Lee, PC; Wu, L; Ang, C; Krall, A; Saeed, A; Stefanini, B; Cammarota, A; Pressiani, T; Abugabal, YI; Chamseddine, S; Wietharn, B; Parisi, A; Huang, YH; Phen, S; Vivaldi, C; Salani, F; Masi, G; Bettinger, D; Vogel, A; von, Felden, J; Schulze, K; Silletta, M; Trauner, M; Samson, A; Wege, H; Piscaglia, F; Galle, PR; Stauber, R; Kudo, M; Singal, AG; Itani, A; Ulahannan, SV; Parikh, ND; Cortellini, A; Kaseb, A; Rimassa, L; Chon, HJ; Pinato, DJ; Pinter, M A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
JHEP Rep. 2024; 6(2): 100982 Doi: 10.1016/j.jhepr.2023.100982 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Brandenburg, A; Heine, A; Brossart, P Next-generation cancer vaccines and emerging immunotherapy combinations.
Trends Cancer. 2024; 10(8): 749-769. Doi: 10.1016/j.trecan.2024.06.003
Web of Science PubMed FullText FullText_MUG

 

Brandlmaier, M; Hoellwerth, M; Silly, T; Hoeller, C; Koch, L; Richtig, E; Binder, K; Lange-Asschenfeldt, B; Barta, M; Schmid-Simbeck, M; Froehlich, F; Dummer, R; Muigg, L; Hitzl, W; Koelblinger, P Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis.
J Eur Acad Dermatol Venereol. 2024; Doi: 10.1111/jdv.20384
Web of Science PubMed FullText FullText_MUG

 

Fetter, T; Fietz, S; Bertlich, M; Braegelmann, C; de, Vos-Hillebrand, L; Wenzel, J; Heine, A; Landsberg, J; Jansen, P Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
Front Immunol. 2024; 15: 1342845 Doi: 10.3389/fimmu.2024.1342845 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hochmair, M; Terbuch, A; Lang, D; Trockenbacher, C; Augustin, F; Ghanim, B; Maurer, D; Taghizadeh, H; Kamhuber, C; Wurm, R; Lindenmann, J; Braz, P; Bundalo, T; Begic, M; Bauer, J; Reimann, P; Müser, N; Huemer, F; Schlintl, V; Bianconi, D; Baumgartner, B; Schenk, P; Rauter, M; Hötzenecker, K Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.
Cancers (Basel). 2024; 16(14): Doi: 10.3390/cancers16142586 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

John, N; Schlintl, V; Sassmann, T; Lindenmann, J; Fediuk, M; Wurm, R; Douschan, P; Zacharias, M; Kalson, L; Posch, F; Absenger, G; Brcic, L; Jost, PJ; Terbuch, A Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
J Immunother Cancer. 2024; 12(4): Doi: 10.1136/jitc-2023-008592 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Koll, FJ; Weers, L; Weigert, A; Banek, S; Köllermann, J; Kluth, L; Wenzel, M; Garcia, CC; Szarvas, T; Wessolly, M; Ingenwerth, M; Jeroch, J; Döring, C; Chun, FK; Wild, PJ; Reis, H Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder.
Mod Pathol. 2024; 37(11): 100588 Doi: 10.1016/j.modpat.2024.100588
Web of Science PubMed FullText FullText_MUG

 

Mispelbaum, R; Hattenhauer, T; Bauernfeind, FG; Lau, JF; Brossart, P; Heine, A Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Front Oncol. 2024; 14:1406616 Doi: 10.3389/fonc.2024.1406616 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Riedl, JM; Barth, D; Berton, F; Fink, M; Englisch, C; Hoeller, C; Fuereder, T; Ay, L; Pabinger, I; Richtig, E; John, N; Kostmann, SM; Jost, PJ; Gerger, A; Terbuch, A; Preusser, M; Ay, C Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors
JACC-CARDIOONCOL. 2024; 6(6): 965-975. Doi: 10.1016/j.jaccao.2024.09.007 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Riedl, JM; Englisch, C; Ay, C Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies.
Hamostaseologie. 2024; 44(1):40-48 Doi: 10.1055/a-2215-9909
Web of Science PubMed FullText FullText_MUG

 

Pichler, R; Fritz, J; Maier, S; Hassler, MR; Krauter, J; D, Andrea, D; Laukhtina, E; Gust, K; Mori, K; Tully, KH; Niedersuess-Beke, D; Korber, L; Spiegelberg, JA; Bauernhofer, T; Subiela, JD; Mayr, R; Kronbichler, A; Moschini, M; Teoh, J; Pradere, B; Shariat, SF; Ulmer, H; Mertens, LS, , European, Association, of, Urology–Young, Academic, Urologists, (EAU-YAU):, Urothelial, Carcinoma, Working, Group Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
Cancer Immunol Immunother. 2024; 74(1): 30 Doi: 10.1007/s00262-024-03871-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Power, JR; Dolladille, C; Ozbay, B; Procureur, AM; Ederhy, S; Palaskas, NL; Lehmann, LH; Cautela, J; Courand, PY; Hayek, SS; Zhu, H; Zaha, VG; Cheng, RK; Alexandre, J; Roubille, F; Baldassarre, LA; Chen, YC; Baik, AH; Laufer-Perl, M; Tamura, Y; Asnani, A; Francis, S; Gaughan, EM; Rainer, PP; Bailly, G; Flint, D; Arangalage, D; Cariou, E; Florido, R; Narezkina, A; Liu, Y; Sandhu, S; Leong, D; Issa, N; Piriou, N; Heinzerling, L; Peretto, G; Crusz, SM; Akhter, N; Levenson, JE; Turker, I; Eslami, A; Fenioux, C; Moliner, P; Obeid, M; Chan, WT; Ewer, SM; Kassaian, SE; Johnson, DB; Nohria, A; Zadok, OIB; Moslehi, JJ; Salem, JE, , International, ICI-Myocarditis, Registry Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity.
medRxiv. 2024; Doi: 10.1101/2024.06.02.24308336 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Suppan, C Escalation of neoadjuvant therapy in triple-negative breast cancer-balancing effectiveness and toxicities
MEMO-MAG EUR MED ONC. 2024; Doi: 10.1007/s12254-024-00997-3
Web of Science FullText FullText_MUG

 

Uhlig, A; Bergmann, L; Bögemann, M; Fischer, T; Goebell, PJ; Leitsmann, M; Reichert, M; Rink, M; Schlack, K; Trojan, L; Uhlig, J; Woike, M; Strauß, A Sunitinib for metastatic renal cell carcinoma: Real world data from the STAR-TOR registry and detailed literature review.
Urol Int. 2024; Doi: 10.1159/000536563
Web of Science PubMed FullText FullText_MUG

 

Verso, M; Moik, F; Graziani, M; Cohen, AT Targeted anti-cancer agents and risk of venous thromboembolism.
Haematologica. 2024; 109(12): 3868-3878. Doi: 10.3324/haematol.2023.284778 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wei, Y; Wang, L; Jin, Z; Jia, Q; Brcic, L; Akaba, T; Chu, Q Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.
Transl Lung Cancer Res. 2024; 13(3): 635-653. Doi: 10.21037/tlcr-24-127 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2023

Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12): Doi: 10.1136/jitc-2023-007765 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Garofalo, M; Wieczorek, M; Anders, I; Staniszewska, M; Lazniewski, M; Prygiel, M; Zasada, AA; Szczepińska, T; Plewczynski, D; Salmaso, S; Caliceti, P; Cerullo, V; Alemany, R; Rinner, B; Pancer, K; Kuryk, L Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
Front Oncol. 2023; 13: 1259314 Doi: 10.3389/fonc.2023.1259314 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Joerg, V; Scheiner, B; D, Alessio, A; Fulgenzi, CAM; Schönlein, M; Kocheise, L; Lohse, AW; Huber, S; Wege, H; Kaseb, A; Wang, Y; Mathew, A; Kuang, A; Muzaffar, M; Abugabal, YI; Chamseddine, S; Phen, S; Cheon, J; Lee, PC; Balcar, L; Krall, A; Ang, C; Wu, L; Saeed, A; Huang, YH; Bengsch, B; Rimassa, L; Weinmann, A; Stauber, R; Korolewicz, J; Pinter, M; Singal, AG; Chon, HJ; Pinato, DJ; Schulze, K; von, Felden, J Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Hepatol Commun. 2023; 7(11): Doi: 10.1097/HC9.0000000000000302 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kaser, S; Hofer, SE; Kazemi-Shirazi, L; Festa, A; Winhofer, Y; Sourij, H; Brath, H; Riedl, M; Resl, M; Clodi, M; Stulnig, T; Ress, C; Luger, A [Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 18-31. Doi: 10.1007/s00508-022-02123-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Maisch, P; Koll, F; Bolenz, C; Chun, FK; Gschwend, JE; Schmid, SC Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
Urol Oncol. 2023; 41(5): 219-232. Doi: 10.1016/j.urolonc.2022.10.009
Web of Science PubMed FullText FullText_MUG

 

Perdyan, A; Sobocki, BK; Balihodzic, A; Dąbrowska, A; Kacperczyk, J; Rutkowski, J The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge-A Systematic Review.
CANCERS. 2023; 15(13): 3490 Doi: 10.3390/cancers15133490 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Perwein, T; Giese, B; Nussbaumer, G; von, Bueren, AO; van, Buiren, M; Benesch, M; Kramm, CM How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.
J Neurooncol. 2023; 161(3):525-538 Doi: 10.1007/s11060-023-04241-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Repas, J; Peternel, L; Sourij, H; Pavlin, M Low glucose availability potentiates the effects of metformin on model T cell activation and exhaustion markers in vitro.
Front Endocrinol (Lausanne). 2023; 14: 1216193 Doi: 10.3389/fendo.2023.1216193 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Voigt, MB; Kravchenko, D; Isaak, A; Heine, A; Holderried, TAW; Luetkens, JA Cardiovascular Magnetic Resonance Assessment of Immunotherapy Cardiotoxicity
CURR CARDIOVASC IMAG. 2023; 16(12): 103-115. Doi: 10.1007/s12410-023-09584-2
Web of Science FullText FullText_MUG

 

Wöll, E; Amann, A; Eisterer, W; Gerger, A; Grünberger, B; Rumpold, H; Weiss, L; Winder, T; Greil, R; Prager, GW Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
Anticancer Res. 2023; 43(7):2889-2897 Doi: 10.21873/anticanres.16460
Web of Science PubMed FullText FullText_MUG

 

2022

Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13:840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bergler-Klein, J; Rainer, PP; Wallner, M; Zaruba, MM; Dörler, J; Böhmer, A; Buchacher, T; Frey, M; Adlbrecht, C; Bartsch, R; Gyöngyösi, M; Fürst, UM Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Wien Klin Wochenschr. 2022; 134(17-18):654-674 Doi: 10.1007/s00508-022-02031-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klümper, N; Saal, J; Berner, F; Lichtensteiger, C; Wyss, N; Heine, A; Bauernfeind, FG; Ellinger, J; Brossart, P; Diem, S; Schmid, S; Joerger, M; Frueh, M; Ritter, M; Hölzel, M; Flatz, L; Bald, T C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
J Immunother Cancer. 2022; 10(3): Doi: 10.1136/jitc-2021-004024 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Ay, C Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
THROMB RES. 2022; 213: S58-S65. Doi: 10.1016/j.thromres.2022.01.004
Web of Science PubMed FullText FullText_MUG

 

Petru, E Endometrial cancer: news from ASCO
MEMO-MAG EUR MED ONC. 2022; Doi: 10.1007/s12254-022-00844-3
Web of Science FullText FullText_MUG

 

Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
BMC Cancer. 2022; 22(1):51 Doi: 10.1186/s12885-021-09115-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Aureli, A; Marziani, B; Sconocchia, T; Del, Principe, MI; Buzzatti, E; Pasqualone, G; Venditti, A; Sconocchia, G Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.
Cancers (Basel). 2021; 13(24): Doi: 10.3390/cancers13246246 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Brcic, L; Mathilakathu, A; Walter, RFH; Wessolly, M; Mairinger, E; Beckert, H; Kreidt, D; Steinborn, J; Hager, T; Christoph, DC; Kollmeier, J; Mairinger, T; Wohlschlaeger, J; Schmid, KW; Borchert, S; Mairinger, FD Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity.
Cancers (Basel). 2021; 13(8): Doi: 10.3390/cancers13081761 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Geiger-Gritsch, S; Olschewski, H; Kocher, F; Wurm, R; Absenger, G; Flicker, M; Hermann, A; Heininger, P; Fiegl, M; Zechmeister, M; Endel, F; Wild, C; Pall, G Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter study.
Wien Klin Wochenschr. 2021; 133(21-22):1122-1130 Doi: 10.1007/s00508-021-01940-w
Web of Science PubMed FullText FullText_MUG

 

Jabkowski, J; Loidl, A; Auinger, B; Kehrer, H; Sepp, N; Pichler, R Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report.
Front Immunol. 2021; 12: 606056 Doi: 10.3389/fimmu.2021.606056 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kaiser, M; Semeraro, MD; Herrmann, M; Absenger, G; Gerger, A; Renner, W Immune Aging and Immunotherapy in Cancer.
Int J Mol Sci. 2021; 22(13): Doi: 10.3390/ijms22137016 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Magnes, T; Wagner, S; Kiem, D; Weiss, L; Rinnerthaler, G; Greil, R; Melchardt, T Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci. 2021; 22(9): Doi: 10.3390/ijms22094981 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Maisch, P; Retz, M; Gschwend, JE; Koll, F; Schmid, SC Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
Urol Int. 2021; 105(1-2): 31-40. Doi: 10.1159/000509431
Web of Science PubMed FullText FullText_MUG

 

Moik, F; Chan, WE; Wiedemann, S; Hoeller, C; Tuchmann, F; Aretin, MB; Fuereder, T; Zöchbauer-Müller, S; Preusser, M; Pabinger, I; Ay, C Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Blood. 2021; 137(12):1669-1678 Doi: 10.1182/blood.2020007878 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum